US EditionNitinotes to initiate US trial of the EndoZip System for endoscopic sleeve gastroplasty
Summary by bariatricnews.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Nitinotes to initiate US trial of the EndoZip System for endoscopic sleeve gastroplasty
Nitinotes has received approval from the FDA to initiate a pivotal clinical trial of the EndoZip System for endoscopic sleeve gastroplasty (ESG) under an Investigational Device Exemption (IDE). This prospective, multi-centre, randomised controlled trial will evaluate the safety and efficacy of the EndoZip System for the treatment of obesity. Up to 184 patients will be enrolled across as many as ten US clinical sites, with additional internationa…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
